Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/8702

Molybdenum trioxide: Target Organs and Levels of Evidence for TR-462

Toxicology and Carcinogenesis Studies of Molybdenum Trioxide (CASRN 1313-27-5) in F344 Rats and B6C3F1 Mice (Inhalation Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Molybdenum trioxide
1313-27-5
Inhalation
0,1,100 MG/M3/10 PER GROUP
Hazleton, Vienna

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Molybdenum trioxide
1313-27-5
12/05/1995 Inhalation
R&M: 10, 30, OR 100 MG/M3; 50/SEX/SPECIES/GROUP
Battelle Northwest Laboratory

Levels of Evidence

Male Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 0/50 0/50 3/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 1/50 1/50 1/50 COMBINED 0/50 1/50 1/50 4/50
Non-Neoplastic Lesions
  • LUNG: CHRONIC INFLAMMATION, ALVEOLUS
  • NASAL CAVITY: HYALINE DEGENERATION, RESPIRATORY EPITHELIUM
  • LARYNX: EPIGLOTTIS, SQUAMOUS METAPLASIA
Female Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • LUNG: CHRONIC INFLAMMATION, ALVEOLUS
  • NASAL CAVITY: RESPIRATORY EPITHELIUM, HYALINE DEGENERATION; OLFACTORY EPITHELIUM, HYALINE DEGENERATION
  • LARYNX: EPIGLOTTIS, SQUAMOUS METAPLASIA
Male Mice: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 9/50 14/50 10/49 9/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 2/50 16/50 14/49 10/50 COMBINED 11/50 27/50 21/49 18/50
Non-Neoplastic Lesions
  • LUNG: ALVEOLAR EPITHELIAL METAPLASIA; INFILTRATION, CELLULAR, HISTIOCYTIC
  • NASAL CAVITY: RESPIRATORY EPITHELIUM, HYALINE DEGENERATION
  • LARYNX: EPIGLOTTIS, SQUAMOUS METAPLASIA, HYPERPLASIA
Female Mice: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 4/50 8/49 9/49 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 2/50 2/50 0/49 6/50 COMBINED 3/50 6/50 8/49 15/49
Non-Neoplastic Lesions
  • LUNG: ALVEOLAR EPITHELIAL METAPLASIA
  • NASAL CAVITY: OLFACTORY EPITHELIUM, HYALINE DEGENERATION; RESPIRATORY EPITHELIUM, HYALINE DEGENERATION
  • LARYNX: EPIGLOTTIS, SQUAMOUS METAPLASIA, HYPERPLASIA